Press Releases

SOUTH SAN FRANCISCO, Calif., Aug. 6, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL), today reported financial results for the second quarter ended June 30, 2019, including sales of TAVALISSE® (fostamatinib disodium hexahydrate) tablets, for the treatment of adults with chronic immune thrombocytopenia (ITP) who have

DUBLIN, Aug. 6, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Phase 1 study of its recombinant crisantaspase molecule, JZP-458, met its efficacy and safety objectives. The company plans to initiate a single-arm, pivotal Phase 2/3 study evaluating JZP-458 as a potential treatment option for patients with acute lymphoblastic le

SOUTH PLAINFIELD, N.J., Aug. 6, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the second quarter ending June 30, 2019. "Over the second quarter we've made important progress towards our strategic plan of building a robust diversified orphan drug f

LEXINGTON, Mass., Aug. 6, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the second quarter ended June 30, 2019."Today, we are excited to announce initial data from our ongoing Phase 1 study of CA-4948 in

SAN DIEGO, Aug. 6, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today reported financial results for the second quarter ended June 30, 2019 and provided an update on recent corporate activities."We are very pleased with the strong progress in both pillars of ou

SALT LAKE CITY, Aug. 6, 2019 /PRNewswire/ -- Varex Imaging Corporation (Nasdaq: VREX) today announced its financial results for the third quarter of fiscal year 2019.

ANAHEIM, California, Aug. 6, 2019 /PRNewswire/ -- Sagentia, the global product development and technology consultancy, today opens its booth at the 71st Annual Scientific Meeting and Clinical Lab Expo (AACC) in support of its activity in Point of Care (PoC) diagnostic systems and consumables.

DALLAS, Aug. 6, 2019 /PRNewswire/ -- The nationally recognized litigation firm of Burns Charest LLP has been retained to represent patent attorney Zachary Silbersher in two federal lawsuits alleging that pharmaceutical companies Valeant and Allergan violated the False Claims Act by fraudulently obtaining patents for Apriso and Namenda

BOSTON, Aug. 6, 2019 /PRNewswire/ -- BBK Worldwide (BBK), the patient experience, recruitment, and engagement leader, today announced that Principal and Director of Accounts and Site Services, David B. Fleishman, was named one of the 100 most inspiring people in life sciences by PharmaVOICE magazine. The award recognizes Mr. Fl

HOUSTON, Aug. 6, 2019 /PRNewswire/ -- The Menninger Clinic, a nationally ranked psychiatric hospital for 30 consecutive years, names Armando E. Colombo